Deals latest: Zeus; KBS leads telematics sale

ZEUS Capital has been appointed joint broker and nominated adviser to MotifBio, an AIM-listed clinical-stage pharma-company.

Zeus, which was last week named North West corporate finance team of the year at The Rainmaker Awards, has also led a £22m fundraising for the Anglo-US business, which is developing new antibiotics.

MotifBio placed 44 million new ordinary shares with institutional investors, through Zeus Capital and Northland Capital Partners as joint brokers, at a placing price of 50p.

The Zeus team included Phil Walker, John Treacy and Dominic Wilson. 

::

NORTH West-based business sales specialist KBS Corporate has advised on the £3.2m sale of DCS Systems to Trakm8 Holdings.

Trakm8 is an AIM-listed telematics company using Big Data analytics to improve driver behaviour and a leading technology designer, developer and manufacturer of telematics products and solutions.

The Dorset-based group distributes its hardware and software through a network of distributors worldwide.

Trakm8 has funded the acquisition from its existing cash and bank facilities.

DCS specialises in the design and distribution of camera systems for the motor vehicle, bicycle and security markets. DCS trades under the three main brands of RoadHawk, Dogcam and Lawmate. Following the deal, DCS will continue to be based in Bodmin, Cornwall.

With cameras being increasingly used in a wide range of applications, including a significant demand for forward facing vehicle cameras to record driving incidents, the acquisition falls in line with Trakm8’s strategy of augmenting its organic growth with selective acquisitions that expand its telematics offering to both insurance and fleet customers.

Trakm8 and DCS have an existing relationship, with DCS supplying a number of Trakm8 customers with its RoadHawk cameras.